Today: 21 May 2026
Wall Street eyes Venezuela shock and U.S. jobs data after Dow, S&P start 2026 higher
4 January 2026
2 mins read

Wall Street eyes Venezuela shock and U.S. jobs data after Dow, S&P start 2026 higher

NEW YORK, Jan 4, 2026, 12:11 PM ET — Market closed

  • The Dow rose 0.67% on Friday, while the S&P 500 gained 0.26% and the Nasdaq added 0.12%.
  • Investors return Monday watching Venezuela developments and the Jan. 9 U.S. employment report for clues on Fed rate cuts.
  • The next big tests land Jan. 13 with U.S. CPI data and early fourth-quarter earnings, including JPMorgan.

Wall Street heads into the first full trading week of 2026 with fresh geopolitical risk on the radar after President Donald Trump said the United States captured Venezuelan leader Nicolas Maduro and would place the oil-rich country under temporary American control. Investors will also be digesting a heavy run of U.S. economic data capped by the monthly jobs report on Jan. 9.

The timing matters because markets are coming out of thin, year-end trading with volatility still subdued and major indexes near record highs. “The market is looking for direction,” said Matthew Maley, chief market strategist at Miller Tabak. Reuters

Valuations leave little room for bad news. Savita Subramanian, Bank of America’s equity and quant strategist, wrote that stocks look expensive on 18 of 20 valuation measures and flagged elevated near-term risk for the index level.

On the last trading day, U.S. stocks ended modestly higher to open 2026. The Dow Jones Industrial Average climbed 321.27 points, or 0.67%, while the S&P 500 added 0.26% and the Nasdaq Composite rose 0.12%.

Bond yields moved up, a headwind that can pressure equity valuations by lifting the return investors can earn in safer assets. The 10-year Treasury yield ended Friday around 4.195%, up about 4 basis points — a basis point is one-hundredth of a percentage point.

Chipmakers helped support the broader market, with the Philadelphia SE Semiconductor index up about 3.5% in the session. Traders also pointed to strength in value-oriented areas such as industrials and utilities after a year in which investors leaned heavily into AI-linked growth themes.

Rate expectations are now the hinge for most equity calls. The Federal Reserve cut interest rates at each of its last three meetings of 2025, and its benchmark rate sits at 3.5% to 3.75%, Reuters reported. Fed funds futures — derivatives that reflect traders’ expectations for where the policy rate will land — point to little chance of a cut at the Fed’s late-January meeting but close to a 50% chance of a quarter-point move in March.

The jobs report on Jan. 9 is the week’s biggest scheduled catalyst. A Reuters poll showed economists expect December payrolls to rise by about 55,000 after a 64,000 increase in November, with the unemployment rate seen at 4.6%, which Reuters said was a more than four-year high in the prior report.

Investors will also get other labor-market signals earlier in the week, including job openings data on Jan. 7, as the government’s economic calendar normalizes after a shutdown that delayed some releases. Inflation will be back in focus on Jan. 13, when the U.S. consumer price index is due.

Earnings season will start to take over the tape. Reuters reported JPMorgan is due to report on Jan. 13, and investors will be listening for guidance on loan demand, trading trends and credit quality, with stocks priced for strong profit growth after a three-year run of gains. LSEG IBES data cited by Reuters showed S&P 500 earnings are expected to rise 15.5% in 2026 after an estimated 13% increase in 2025.

But the downside scenario is straightforward: a weaker-than-expected jobs report could revive recession fears, while sticky inflation could push yields higher and force a rethink of rich equity valuations. Traders also warned that any oil-price volatility tied to Venezuela could ripple across risk assets, while Reuters noted other political catalysts ahead including a looming U.S. Supreme Court decision on Trump’s tariffs and his choice of a new Fed chair.

The next clear markers for investors are Monday’s return to regular U.S. trading, then Jan. 7 job openings data, the Jan. 9 employment report, and Jan. 13’s CPI release and early big-bank earnings.

Stock Market Today

  • CyberTech Systems Earnings Raise Cash Flow Concerns Amid Market Stability
    May 20, 2026, 8:56 PM EDT. CyberTech Systems and Software Limited (NSE:CYBERTECH) posted earnings that met market expectations but revealed an accrual ratio of 0.53, indicating weaker free cash flow relative to profit. This financial metric, which measures non-cash earnings, signals potential challenges for upcoming profits as free cash flow of ₹76 million lagged behind reported profit of ₹304.3 million for the year ending March 2026. Despite a 28% annual growth in earnings per share (EPS) over three years, the decline in cash conversion may raise investor caution. The company's accrual ratio improved last year, suggesting the current shortfall could be temporary, but shareholders are advised to monitor cash flow trends closely against profitability for a clearer outlook.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
ASX Ltd stock today: shares cling to the low end of the 52-week range as 2026 opens quietly
Previous Story

ASX Ltd stock today: shares cling to the low end of the 52-week range as 2026 opens quietly

Tesco issues urgent “do not eat” recall for three pate lines after date-label error
Next Story

Tesco issues urgent “do not eat” recall for three pate lines after date-label error

Go toTop